NLS - Research Biophilia Tracker X3 and Cervical Cancer

NLS - Research Biophilia Tracker X3 and Cervical Cancer

Cervical malignancies lead the world and are considered to be the main cause of tumor morbidity and mortality structure. Cervical cancer (CUC) ranks fourth in prevalence after gastric cancer, respiratory cancer and skin cancer. Despite mass preventive testing using cytology screening, the incidence of invasive cervical cancer has declined slowly. Therefore, accurate assessment of disease expansion becomes very important—otherwise it is difficult to select appropriate treatments. Today, to meet this requirement, not only are various invasive diagnostic methods used, but we are seeing more and more use cases for NLS research. Due to its high informative value, non-invasive base, no radiation stress, and versatility, NLS studies have become quite common as the most economical, simple, and simultaneously reliable method for evaluating small pelvic organs. However, the detection of cervical lesions by NLS methods remains a controversial and unexplored issue. Due to the active development of computer technology and the introduction of 3D NLS research, we are faced with an urgent need to revise the previously described NLS mapping potential based only on 2D research results. Considering that surgical treatment of patients with invasive cervical cancer is not possible, we should correlate data obtained from NLS and MR imaging by assessing tumor size, borders, and extent of disease to examine the accuracy of NLS study results .

The NLS-study of the cervix was performed using the Biophilia Tracker X3 system with a generator frequency of 4.9GHz and a continuous helical scanning unit, in conjunction with the professional computer software metatron 4025 Hunter, enabling us to perform 2D and 3D visualization of the uterus.